Larger vials (20mg+) make more sense once you have reached maintenance doses and confirmed retatrutide works well for your research goals
Wellness injections at California Infusion Centers are administered by licensed clinicians under medical supervision using proper screening and sterile protocols

Pull-Down Assay Service Modules We Offer ProteinProtein Interaction (Co-IP / APMS) Capture native or recombinant complexes using GST, His, FLAG, HA, or biotin tags Adjustable wash stringency tiers to balance specificity and yield End-to-end support from bait validation to MS-based interactor profiling Small Molecule / PROTAC / Fragment-Based Pull-Down Covalently couple compounds to solid supports via amine/NHS or alkyne/click chemistries Include competitive elution to confirm binding specificity Ideal for chemoproteomics, target deconvolution, or hit validation Use biotinylated oligos, structure-stabilized aptamers, or motifs Optional RNase/DNase protection strategies Scrambled/mutant sequence controls to verify sequence specificity Lipid or Membrane-Targeted Pull-Down Employ lipid-coated beads, liposomes, or nanodiscs Enrich lipid-binding proteins or membrane-associated complexes Compatible with detergents and membrane mimetics Crosslinking-Assisted Capture Stabilize weak or transient interactions using MS-compatible crosslinkers (e.g., DSSO, BS3, DSP) Applicable to dynamic complexes or interaction time-course studies Combine with label-free or TMT quantification for comparative analyses Quantitative Mass Spectrometry Readouts Label-Free Quantification (LFQ): For simple comparisons and pilot studies TMT/iTRAQ Multiplexing: For multi-condition, high-throughput workflows (up to 18-plex) Targeted Validation: Confirm top hits using PRM (Orbitrap) or MRM (Triple Quad) Data-Independent Acquisition (DIA): For robust, reproducible depth across samples When to Choose Each Pull-Down Modality Tagged bait available, unknown partners : Proteinprotein pull-down with tag-only and beads-only controls

BSO treatment increased the transcription of these transporters (Figure 5)